{
  "data": [
    [
      "1",
      "NCT04260308",
      "ClinicalTrials.gov",
      "2020-02-03",
      "2020-02-03",
      "False",
      "Huazhong University of Science and Technology",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia",
      "",
      "Other (psych)",
      "No Intervention",
      "No Intervention",
      "30000",
      "2020-04-15",
      "2020-04-20",
      "https://clinicaltrials.gov/show/NCT04260308",
      "Pre-Print Article",
      "2020-03-06",
      "https://doi.org/10.1101/2020.03.03.20030874",
      "2020-02-17",
      "None"
    ],
    [
      "19",
      "ChiCTR2000029853",
      "ChiCTR",
      "2020-02-15",
      "2020-02-16",
      "False",
      "People's Hospital of Guangshan County",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Azvudine",
      "Azvudine",
      "20",
      "Not Available",
      "2020-04-16",
      "http://www.chictr.org.cn/showproj.aspx?proj=49532",
      "Journal Article",
      "2020-07-14",
      "https://doi.org/10.1002/advs.202001435",
      "2020-02-17",
      "None"
    ],
    [
      "46",
      "ChiCTR2000029758",
      "ChiCTR",
      "2020-02-12",
      "2020-02-03",
      "True",
      "West China Hospital of Sichuan University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "100",
      "Not Available",
      "2022-02-01",
      "http://www.chictr.org.cn/showproj.aspx?proj=49295",
      "Pre-Print Article",
      "2020-03-06",
      "https://doi.org/10.1101/2020.03.22.20041277",
      "2020-02-17",
      "None"
    ],
    [
      "55",
      "ChiCTR2000029734",
      "ChiCTR",
      "2020-02-10",
      "2020-02-08",
      "True",
      "The First People's Hospital of Huaihua",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19)",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "40",
      "Not Available",
      "2020-08-07",
      "http://www.chictr.org.cn/showproj.aspx?proj=48868",
      "Pre-Print Article",
      "2020-03-06",
      "https://doi.org/10.1101/2020.03.04.20026005",
      "2020-02-17",
      "None"
    ],
    [
      "67",
      "ChiCTR2000029609",
      "ChiCTR",
      "2020-02-06",
      "2020-02-10",
      "False",
      "The Fifth Affiliated Hospital of Sun Yat-Sen University",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Chloroquine vs. lopinavir/ritonavir",
      "Chloroquine; lopinavir; ritonavir",
      "205",
      "Not Available",
      "2020-12-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=49145",
      "Pre-Print Article",
      "2020-05-04",
      "https://doi.org/10.1101/2020.04.26.20081059",
      "2020-02-17",
      "None"
    ],
    [
      "72",
      "ChiCTR2000029600",
      "ChiCTR",
      "2020-02-06",
      "2020-01-30",
      "True",
      "The Third People's Hospital of Shenzhen",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Favipiravir + interferon alpha vs. interferon alpha + Lopinavir/ritonavir + interferon alpha vs. interferon alpha",
      "Favipiravir; interferon alpha; Lopinavir/ritonavir",
      "90",
      "Not Available",
      "2020-04-29",
      "http://www.chictr.org.cn/showproj.aspx?proj=49042",
      "Journal Article",
      "2020-03-18",
      "https://doi.org/10.1016/j.eng.2020.03.007",
      "2020-02-17",
      "None"
    ],
    [
      "74",
      "ChiCTR2000029559",
      "ChiCTR",
      "2020-02-04",
      "2020-01-31",
      "True",
      "Renmin Hospital of Wuhan University",
      "Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "300",
      "Not Available",
      "2020-02-29",
      "http://www.chictr.org.cn/showproj.aspx?proj=48880",
      "Pre-Print Article",
      "2020-03-31",
      "https://doi.org/10.1101/2020.03.22.20040758",
      "2020-02-17",
      "None"
    ],
    [
      "77",
      "ChiCTR2000029544",
      "ChiCTR",
      "2020-02-03",
      "2020-02-04",
      "False",
      "The First Affiliated Hospital of Zhejiang University School of Medicine",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",
      "",
      "Drug",
      "Baloxavir + Marboxil vs. Favipiravir",
      "Baloxavir; Marboxil; Favipiravir",
      "30",
      "Not Available",
      "2020-05-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=49013",
      "Pre-Print Article",
      "2020-05-05",
      "https://doi.org/10.1101/2020.04.29.20085761",
      "2020-02-17",
      "None"
    ],
    [
      "97",
      "ChiCTR2000029431",
      "ChiCTR",
      "2020-02-01",
      "2020-01-29",
      "True",
      "Affiliated Zhongshan Hospital of Dalian University",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19)",
      "",
      "Traditional Medicine (Drug)",
      "Traditional Medicine",
      "Traditional Medicine",
      "45",
      "Not Available",
      "2021-12-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=48907",
      "Pre-Print Article",
      "2020-04-14",
      "https://doi.org/10.1101/2020.04.07.20054767",
      "2020-02-17",
      "None"
    ],
    [
      "99",
      "ChiCTR2000029418",
      "ChiCTR",
      "2020-01-30",
      "2020-02-03",
      "False",
      "Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial",
      "",
      "Traditional Medicine (Drug)",
      "Traditional Medicine",
      "Traditional Medicine",
      "42",
      "Not Available",
      "2020-08-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=48886",
      "Pre-Print Article",
      "2020-04-01",
      "https://doi.org/10.1101/2020.03.27.20044974",
      "2020-02-17",
      "None"
    ],
    [
      "133",
      "ChiCTR2000030054",
      "ChiCTR",
      "2020-02-22",
      "2020-02-22",
      "False",
      "Zhongshan Hospital Affiliated to Xiamen University",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",
      "",
      "Drug",
      "Chloroquine + Hydroxychloroquine",
      "Chloroquine; Hydroxychloroquine",
      "100",
      "Not Available",
      "2020-05-21",
      "http://www.chictr.org.cn/showproj.aspx?proj=49869",
      "Pre-Print Article",
      "2020-06-22",
      "https://doi.org/10.1101/2020.06.19.20136093",
      "2020-02-25",
      "None"
    ],
    [
      "134",
      "ChiCTR2000030046",
      "ChiCTR",
      "2020-02-21",
      "2020-02-07",
      "True",
      "The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19)",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "10",
      "Not Available",
      "2020-08-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=49861",
      "Journal Article",
      "2020-07-21",
      "https://doi.org/10.1073/pnas.2004168117",
      "2020-02-25",
      "None"
    ],
    [
      "149",
      "ChiCTR2000030015",
      "ChiCTR",
      "2020-02-20",
      "2020-02-19",
      "True",
      "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "Recruiting",
      "Not Applicable",
      "Basic Science",
      "China",
      "Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "300",
      "Not Available",
      "2020-08-19",
      "http://www.chictr.org.cn/showproj.aspx?proj=49800",
      "Pre-Print Article",
      "2020-03-30",
      "https://doi.org/10.1101/2020.03.26.20043943",
      "2020-02-25",
      "None"
    ],
    [
      "165",
      "ChiCTR2000029990",
      "ChiCTR",
      "2020-02-18",
      "2020-01-30",
      "True",
      "Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",
      "Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "China",
      "Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19)",
      "",
      "ATMP",
      "Cells (mesenchymal)",
      "Cells (mesenchymal)",
      "120",
      "Not Available",
      "2020-03-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=49674",
      "Journal Article",
      "2020-03-13",
      "https://doi.org/10.14336/AD.2020.0228",
      "2020-02-25",
      "None"
    ],
    [
      "169",
      "ChiCTR2000029981",
      "ChiCTR",
      "2020-02-18",
      "2020-02-18",
      "False",
      "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "Recruiting",
      "Not Applicable",
      "Diagnostic test",
      "China",
      "Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "60",
      "Not Available",
      "2020-05-18",
      "http://www.chictr.org.cn/showproj.aspx?proj=49692",
      "Pre-Print Article",
      "2020-03-03",
      "https://doi.org/10.1101/2020.02.26.20028225",
      "2020-02-25",
      "None"
    ],
    [
      "178",
      "ChiCTR2000029851",
      "ChiCTR",
      "2020-02-15",
      "2020-02-19",
      "False",
      "Zhongshan Hospital, Fudan University",
      "Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",
      "",
      "Supplement",
      "Alpha lipoic acid",
      "Alpha lipoic acid",
      "68",
      "Not Available",
      "2020-03-10",
      "http://www.chictr.org.cn/showproj.aspx?proj=49534",
      "Pre-Print Article",
      "2020-04-21",
      "https://doi.org/10.1101/2020.04.15.20066266",
      "2020-02-25",
      "None"
    ],
    [
      "186",
      "NCT04275245",
      "ClinicalTrials.gov",
      "2020-02-06",
      "2020-02-03",
      "True",
      "Tang-Du Hospital",
      "Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "China",
      "Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia",
      "",
      "Drug",
      "Mepolizumab",
      "Mepolizumab",
      "20",
      "2020-12-31",
      "2020-12-31",
      "https://clinicaltrials.gov/show/NCT04275245",
      "Pre-Print Article",
      "2020-03-24",
      "https://doi.org/10.1101/2020.03.21.20040691",
      "2020-03-02",
      "None"
    ],
    [
      "187",
      "NCT04275947",
      "ClinicalTrials.gov",
      "2020-02-17",
      "2020-02-14",
      "True",
      "Chinese Alliance Against Lung Cancer",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "The COVID-19 Mobile Health Study (CMHS)",
      "CMHS",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "450",
      "2020-04-30",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04275947",
      "Pre-Print Article",
      "2020-08-11",
      "https://doi.org/10.1101/2020.08.07.20163402",
      "2020-03-02",
      "None"
    ],
    [
      "199",
      "ChiCTR2000030391",
      "ChiCTR",
      "2020-03-01",
      "2020-03-01",
      "False",
      "Lishui Central Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "100",
      "Not Available",
      "Not Available",
      "http://www.chictr.org.cn/showproj.aspx?proj=30796",
      "Pre-Print Article",
      "2020-04-29",
      "https://doi.org/10.1101/2020.04.25.20079079",
      "2020-03-02",
      "None"
    ],
    [
      "200",
      "ChiCTR2000030390",
      "ChiCTR",
      "2020-03-01",
      "2020-01-01",
      "True",
      "Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine",
      "Recruiting",
      "Not Applicable",
      "Diagnostic test",
      "China",
      "Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "3000",
      "Not Available",
      "2020-06-01",
      "http://www.chictr.org.cn/showproj.aspx?proj=50224",
      "Pre-Print Article",
      "2020-05-15",
      "https://doi.org/10.1101/2020.05.11.20093732",
      "2020-03-02",
      "None"
    ],
    [
      "245",
      "ChiCTR2000029387",
      "ChiCTR",
      "2020-01-29",
      "2020-01-25",
      "True",
      "Chongqing Public Health Medical Center",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",
      "",
      "Drug",
      "Ribavirin + Interferon alfa\nvs. lopinavir/ritonavir + interferon alfa\nvs. ribavirin + interferon alfa vs. lopinavir/ritonavir",
      "Ribavirin; Interferon alpha; Lopinavir; Ritonavir",
      "108",
      "Not Available",
      "2021-01-25",
      "http://www.chictr.org.cn/showproj.aspx?proj=48782",
      "Journal Article",
      "2020-07-14",
      "https://doi.org/10.3389/fphar.2020.01071",
      "2020-03-02",
      "None"
    ],
    [
      "252",
      "ChiCTR2000030627",
      "ChiCTR",
      "2020-03-08",
      "2020-02-01",
      "True",
      "The First Affiliated Hospital of Zhengzhou University",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "30",
      "Not Available",
      "2020-05-30",
      "http://www.chictr.org.cn/showproj.aspx?proj=50727",
      "Pre-Print Article",
      "2020-08-04",
      "https://doi.org/10.1101/2020.08.02.20166710",
      "2020-03-09",
      "None"
    ],
    [
      "265",
      "ChiCTR2000030542",
      "ChiCTR",
      "2020-03-06",
      "2020-03-09",
      "False",
      "West China Hospital of Sichuan University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",
      "",
      "Genomics",
      "No Intervention",
      "No Intervention",
      "600",
      "Not Available",
      "2020-07-30",
      "http://www.chictr.org.cn/showproj.aspx?proj=50608",
      "Pre-Print Article",
      "2020-03-21",
      "https://doi.org/10.1101/2020.03.18.20035816",
      "2020-03-09",
      "None"
    ],
    [
      "275",
      "ChiCTR2000030489",
      "ChiCTR",
      "2020-03-04",
      "2020-02-01",
      "True",
      "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "Recruiting",
      "Not Applicable",
      "Epidemiological research",
      "China",
      "Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "1000",
      "Not Available",
      "2020-06-30",
      "http://www.chictr.org.cn/showproj.aspx?proj=50490",
      "Pre-Print Article",
      "2020-03-16",
      "https://doi.org/10.1101/2020.03.12.20034678",
      "2020-03-09",
      "None"
    ],
    [
      "297",
      "ChiCTR2000029757",
      "ChiCTR",
      "2020-02-12",
      "2020-02-14",
      "False",
      "China-Japan Friendship Hospital",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "200",
      "Not Available",
      "2021-02-05",
      "http://www.chictr.org.cn/showproj.aspx?proj=49081",
      "Journal Article",
      "2020-06-03",
      "https://doi.org/10.1001/jama.2020.10044",
      "2020-03-09",
      "None"
    ],
    [
      "298",
      "ChiCTR2000029580",
      "ChiCTR",
      "2020-02-05",
      "2020-01-31",
      "True",
      "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",
      "",
      "Drug (+ ATMP)",
      "Ruxolimab + Cells (mesenchymal)",
      "Ruxolimab; Cells (mesenchymal)",
      "70",
      "Not Available",
      "2020-12-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=49088",
      "Journal Article",
      "2020-05-26",
      "https://doi.org/10.1016/j.jaci.2020.05.019",
      "2020-03-09",
      "None"
    ],
    [
      "302",
      "ChiCTR2000029308",
      "ChiCTR",
      "2020-01-23",
      "2020-01-10",
      "True",
      "Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital)",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Lopinavir/ritonavir",
      "lopinavir/ritonavir",
      "160",
      "Not Available",
      "2021-01-10",
      "http://www.chictr.org.cn/showproj.aspx?proj=48684",
      "Journal Article",
      "2020-03-18",
      "https://doi.org/10.1056/NEJMoa2001282",
      "2020-03-09",
      "None"
    ],
    [
      "332",
      "ChiCTR2000030852",
      "ChiCTR",
      "2020-03-16",
      "2020-01-27",
      "True",
      "Beijing An Zhen Hospital, Capital Medical University",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Factors associated with death in patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Prognosis",
      "No Intervention",
      "No Intervention",
      "150",
      "Not Available",
      "2020-02-27",
      "http://www.chictr.org.cn/showproj.aspx?proj=51077",
      "Journal Article",
      "2020-03-11",
      "https://doi.org/10.1016/S0140-6736(20)30566-3",
      "2020-03-16",
      "None"
    ],
    [
      "363",
      "ChiCTR2000030795",
      "ChiCTR",
      "2020-03-15",
      "2020-03-20",
      "False",
      "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "90",
      "Not Available",
      "2020-05-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=50982",
      "Journal Article",
      "2020-05-22",
      "http://dx.doi.org/10.1136/annrheumdis-2020-217627",
      "2020-03-16",
      "None"
    ],
    [
      "378",
      "ChiCTR2000030756",
      "ChiCTR",
      "2020-03-13",
      "2020-02-20",
      "True",
      "Shenzhen Hospital of Southern Medical University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Clinical Presentation ",
      "No Intervention",
      "No Intervention",
      "60",
      "Not Available",
      "2020-08-20",
      "http://www.chictr.org.cn/showproj.aspx?proj=50705",
      "Pre-Print Article",
      "2020-03-30",
      "https://doi.org/10.1101/2020.03.26.20044198",
      "2020-03-16",
      "None"
    ],
    [
      "403",
      "ChiCTR2000030697",
      "ChiCTR",
      "2020-03-10",
      "2020-03-10",
      "False",
      "Ningbo First Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",
      "",
      "Other (psych)",
      "Psychological",
      "Psychological",
      "1500",
      "Not Available",
      "2021-03-10",
      "http://www.chictr.org.cn/showproj.aspx?proj=50781",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.03.13.20033290\n\nhttps://doi.org/10.1101/2020.03.22.20040899",
      "2020-03-16",
      "None"
    ],
    [
      "404",
      "ChiCTR2000030690",
      "ChiCTR",
      "2020-03-10",
      "2020-02-10",
      "True",
      "The Third Affiliated Hospital of the Second Military Medical University",
      "Recruiting",
      "Not Applicable",
      "Basic Science",
      "China",
      "Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "30",
      "Not Available",
      "2021-02-10",
      "http://www.chictr.org.cn/showproj.aspx?proj=50261",
      "Pre-Print Article",
      "2020-03-31",
      "https://doi.org/10.1101/2020.03.23.20039362",
      "2020-03-16",
      "None"
    ],
    [
      "420",
      "ChiCTR2000030055",
      "ChiCTR",
      "2020-02-22",
      "2020-02-10",
      "True",
      "The First Affiliated Hospital of Guangzhou Medical University",
      "Recruiting",
      "Phase 4",
      "Prognosis",
      "China",
      "Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Dipyridamole",
      "Dipyridamole",
      "460",
      "Not Available",
      "2020-04-10",
      "http://www.chictr.org.cn/showproj.aspx?proj=49864",
      "Journal Article",
      "2020-02-29",
      "https://dx.doi.org/10.1007%2Fs12250-020-00258-7",
      "2020-03-16",
      "None"
    ],
    [
      "457",
      "ChiCTR2000030939",
      "ChiCTR",
      "2020-03-18",
      "2020-03-16",
      "True",
      "PLA General Hospital",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19)",
      "",
      "ATMP",
      "Gene-derived protein",
      "Gene-derived protein",
      "10",
      "Not Available",
      "2020-10-01",
      "http://www.chictr.org.cn/showproj.aspx?proj=51059",
      "Pre-Print Article",
      "2020-05-15",
      "https://doi.org/10.1101/2020.05.11.20064584",
      "2020-03-23",
      "None"
    ],
    [
      "470",
      "ChiCTR2000030254",
      "ChiCTR",
      "2020-02-26",
      "2020-02-20",
      "True",
      "Zhongnan Hospital of Wuhan University",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "the Efficacy and Safety of Favipiravir for novel coronavirus\u2013infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",
      "",
      "Drug",
      "Favipiravir vs. Umifenovir",
      "Favipiravir; Umifenovir",
      "240",
      "Not Available",
      "2020-03-20",
      "http://www.chictr.org.cn/showproj.aspx?proj=50137",
      "Pre-Print Article",
      "2020-03-27",
      "https://doi.org/10.1101/2020.03.17.20037432",
      "2020-03-23",
      "None"
    ],
    [
      "473",
      "ChiCTR2000029868",
      "ChiCTR",
      "2020-02-15",
      "2020-02-11",
      "True",
      "Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",
      "",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "360",
      "Not Available",
      "2020-06-30",
      "http://www.chictr.org.cn/showproj.aspx?proj=49524",
      "Journal Article",
      "2020-05-14",
      "https://doi.org/10.1136/bmj.m1849",
      "2020-03-23",
      "None"
    ],
    [
      "475",
      "ChiCTR2000029658",
      "ChiCTR",
      "2020-02-09",
      "2020-02-10",
      "False",
      "Central Theater General Hospital of PLA",
      "No Status Given",
      "Not Applicable",
      "Interventional",
      "China",
      "Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19)",
      "",
      "Other (physical)",
      "Mechanical ventilation",
      "Mechanical ventilation",
      "60",
      "Not Available",
      "2020-04-06",
      "http://www.chictr.org.cn/showproj.aspx?proj=49074",
      "Correspondence",
      "2020-03-19",
      "https://doi.org/10.1016/j.bja.2020.02.020",
      "2020-03-23",
      "None"
    ],
    [
      "476",
      "ChiCTR2000029658",
      "ChiCTR",
      "2020-02-09",
      "2020-02-10",
      "False",
      "Central Theater General Hospital of PLA",
      "No Status Given",
      "Not Applicable",
      "Interventional",
      "China",
      "Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19)",
      "",
      "Other (physical)",
      "Mechanical ventilation",
      "Mechanical ventilation",
      "60",
      "Not Available",
      "2020-04-06",
      "http://www.chictr.org.cn/showproj.aspx?proj=49074",
      "Journal Article",
      "2020-03-20",
      "https://doi.org/10.1016/j.bja.2020.02.020",
      "2020-03-23",
      "None"
    ],
    [
      "478",
      "ChiCTR2000029496",
      "ChiCTR",
      "2020-02-03",
      "2020-01-29",
      "True",
      "The First Hospital of Changsha; The Second Xiangya Hospital of Central South University",
      "Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",
      "",
      "ATMP",
      "Gene-derived protein",
      "Gene-derived protein",
      "90",
      "Not Available",
      "2021-01-29",
      "http://www.chictr.org.cn/showproj.aspx?proj=48809",
      "Journal Article",
      "2020-08-02",
      "https://doi.org/10.1016/j.ijid.2020.07.053",
      "2020-03-23",
      "None"
    ],
    [
      "479",
      "EUCTR2020-000890-25-FR",
      "EU Clinical Trials Register",
      "2020-03-10",
      "2020-03-05",
      "True",
      "Fondation M\u00e9diterran\u00e9e Infection (FMI) - IHU M\u00e9diterran\u00e9e Infection",
      "Authorised",
      "Phase 3",
      "Interventional",
      "France",
      "Hydroxychloroquine as a treatment for coronavirus disease COVID-19",
      "",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "25",
      "Not Available",
      "Not Available",
      "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25",
      "Journal Article",
      "2020-03-20",
      "https://doi.org/10.1016/j.ijantimicag.2020.105949",
      "2020-03-23",
      "None"
    ],
    [
      "489",
      "NCT04292964",
      "ClinicalTrials.gov",
      "2020-03-01",
      "2020-03-01",
      "False",
      "Chongqing Medical University",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Prognostic Factors of Patients With COVID-19",
      "",
      "Prognosis",
      "No Intervention",
      "No Intervention",
      "201",
      "2020-03-13",
      "2020-03-13",
      "https://clinicaltrials.gov/show/NCT04292964",
      "Journal Article",
      "2020-04-15",
      "http://dx.doi.org/10.1186/s12931-020-01352-w",
      "2020-03-30",
      "None"
    ],
    [
      "502",
      "ChiCTR2000031365",
      "ChiCTR",
      "2020-03-29",
      "2020-01-17",
      "True",
      "Westlake University",
      "Recruiting",
      "Not Applicable",
      "Diagnostic test",
      "China",
      "To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients",
      "",
      "Prognosis",
      "No Intervention",
      "No Intervention",
      "0",
      "Not Available",
      "2022-01-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=51694",
      "Pre-Print Article",
      "2020-04-07",
      "https://doi.org/10.1101/2020.04.07.20054585",
      "2020-03-30",
      "None"
    ],
    [
      "513",
      "ChiCTR2000031296",
      "ChiCTR",
      "2020-03-27",
      "2020-01-14",
      "True",
      "Yichang Central People's Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "200",
      "Not Available",
      "2020-03-19",
      "http://www.chictr.org.cn/showproj.aspx?proj=51584",
      "Pre-Print Article",
      "2020-03-30",
      "https://doi.org/10.1101/2020.03.26.20041426",
      "2020-03-30",
      "None"
    ],
    [
      "559",
      "ChiCTR2000031630",
      "ChiCTR",
      "2020-04-05",
      "2020-02-17",
      "True",
      "Guangzhou Eighth People's Hospital",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19)",
      "",
      "Drug",
      "Celecoxib",
      "Celecoxib",
      "60",
      "Not Available",
      "2020-06-17",
      "http://www.chictr.org.cn/showproj.aspx?proj=50474",
      "Pre-Print Article",
      "2020-05-11",
      "https://doi.org/10.1101/2020.05.05.20077610",
      "2020-04-06",
      "None"
    ],
    [
      "570",
      "ChiCTR2000031494",
      "ChiCTR",
      "2020-04-02",
      "2020-02-01",
      "True",
      "Huangshi Hospital of Traditional Chinese Medicine",
      "Recruiting",
      "Phase 1",
      "Interventional",
      "China",
      "Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19)",
      "",
      "ATMP",
      "Cells (mesenchymal)",
      "Cells (mesenchymal)",
      "36",
      "Not Available",
      "2020-12-02",
      "http://www.chictr.org.cn/showproj.aspx?proj=51904",
      "Journal Article",
      "2020-08-18",
      "https://dx.doi.org/10.1186%2Fs13287-020-01875-5",
      "2020-04-06",
      "None"
    ],
    [
      "583",
      "NCT04320238",
      "ClinicalTrials.gov",
      "2020-03-21",
      "2020-01-21",
      "True",
      "Shanghai Jiaotong University",
      "Recruiting",
      "Phase 3",
      "Interventional",
      "China",
      "Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff",
      "",
      "Drug",
      "Interferon Alpha vs. Interferon Alpha + Thymosin Alpha",
      "Interferon alpha; Thymosin alpha",
      "2944",
      "2020-05-20",
      "2020-06-20",
      "https://clinicaltrials.gov/show/NCT04320238",
      "Pre-Print Article",
      "2020-04-17",
      "https://doi.org/10.1101/2020.04.11.20061473",
      "2020-04-14",
      "None"
    ],
    [
      "640",
      "NCT04252274",
      "ClinicalTrials.gov",
      "2020-01-29",
      "2020-01-30",
      "False",
      "Shanghai Public Health Clinical Center",
      "Recruiting",
      "Phase 3",
      "Interventional",
      "China",
      "Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19",
      "DC-COVID-19",
      "Drug",
      "Darunavir + Cobicistat",
      "Darunavir; Cobicistat",
      "30",
      "2020-08-31",
      "2020-12-31",
      "https://clinicaltrials.gov/show/NCT04252274",
      "Journal Article",
      "2020-06-21",
      "https://doi.org/10.1093/ofid/ofaa241",
      "2020-04-20",
      "None"
    ],
    [
      "641",
      "NCT04261517",
      "ClinicalTrials.gov",
      "2020-02-06",
      "2020-02-06",
      "False",
      "Shanghai Public Health Clinical Center",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "China",
      "Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19",
      "",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "30",
      "2020-02-25",
      "2020-02-25",
      "https://clinicaltrials.gov/show/NCT04261517",
      "Journal Article",
      "2020-03-06",
      "https://doi.org/10.3785/j.issn.1008-9292.2020.03.03",
      "2020-04-20",
      "None"
    ],
    [
      "643",
      "NCT04291729",
      "ClinicalTrials.gov",
      "2020-02-27",
      "2020-02-17",
      "True",
      "The Ninth Hospital of Nanchang",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection",
      "",
      "Drug",
      "Danoprevir + Ritonavir (w/ or w/o Interferon)",
      "Danoprevir; Ritonavir; Interferon",
      "11",
      "2020-03-19",
      "2020-03-19",
      "https://clinicaltrials.gov/show/NCT04291729",
      "Pre-Print Article",
      "2020-03-24",
      "https://doi.org/10.1101/2020.03.22.20034041",
      "2020-04-20",
      "None"
    ],
    [
      "647",
      "NCT04315480",
      "ClinicalTrials.gov",
      "2020-03-14",
      "2020-03-12",
      "True",
      "Universit Politecnica delle Marche",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Italy",
      "Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis",
      "",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "38",
      "2020-04-09",
      "2020-05-20",
      "https://clinicaltrials.gov/show/NCT04315480",
      "Pre-Print Article",
      "2020-07-11",
      "https://doi.org/10.1101/2020.07.11.20151365",
      "2020-04-20",
      "None"
    ],
    [
      "648",
      "NCT04319315",
      "ClinicalTrials.gov",
      "2020-03-16",
      "2020-03-11",
      "True",
      "Assiut University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Egypt",
      "Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak",
      "",
      "Other",
      "No Intervention",
      "No Intervention",
      "400",
      "2020-04-01",
      "2020-04-16",
      "https://clinicaltrials.gov/show/NCT04319315",
      "Pre-Print Article",
      "2020-06-03",
      "https://doi.org/10.1101/2020.05.31.20118232",
      "2020-04-20",
      "None"
    ],
    [
      "649",
      "NCT04321369",
      "ClinicalTrials.gov",
      "2020-03-23",
      "2020-03-09",
      "True",
      "Dr. Deneen Vojta",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "533",
      "2020-03-23",
      "2020-03-23",
      "https://clinicaltrials.gov/show/NCT04321369",
      "Pre-Print Article",
      "2020-04-06",
      "https://doi.org/10.1101/2020.04.01.20050005",
      "2020-04-20",
      "None"
    ],
    [
      "653",
      "NCT04331509",
      "ClinicalTrials.gov",
      "2020-03-31",
      "2020-03-23",
      "True",
      "King's College London",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United States, United Kingdom",
      "COVID-19 Symptom Tracker",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "10000000",
      "2022-03-23",
      "2022-03-23",
      "https://clinicaltrials.gov/show/NCT04331509",
      "Pre-Print Article",
      "2020-05-12",
      "https://doi.org/10.1101/2020.04.29.20084111",
      "2020-04-20",
      "None"
    ],
    [
      "724",
      "IRCT20100228003449N28",
      "IRCT",
      "2020-03-19",
      "2020-03-15",
      "True",
      "Tehran University of Medical Sciences",
      "Not Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Iran",
      "Interferon in treatment of COVID-19",
      "",
      "Drug",
      "Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir",
      "Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir",
      "30",
      "Not Available",
      "Not Available",
      "http://en.irct.ir/trial/46538",
      "Journal Article",
      "2020-08-20",
      "https://doi.org/10.1128/AAC.01061-20",
      "2020-04-21",
      "None"
    ],
    [
      "725",
      "IRCT20100228003449N27",
      "IRCT",
      "2020-03-16",
      "2020-03-15",
      "True",
      "Tehran University of Medical Sciences",
      "Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Iran",
      "Interferon \u00df in treatment  of COVID-19",
      "",
      "Drug",
      "Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir",
      "Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir",
      "30",
      "Not Available",
      "Not Available",
      "http://en.irct.ir/trial/46545",
      "Journal Article",
      "2020-08-24",
      "https://doi.org/10.1016/j.intimp.2020.106903",
      "2020-04-21",
      "None"
    ],
    [
      "760",
      "NCT04257656",
      "ClinicalTrials.gov",
      "2020-01-31",
      "2020-02-06",
      "False",
      "Capital Medical University",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "China",
      "A Trial of Remdesivir in Adults With Severe COVID-19",
      "",
      "Drug",
      "Remdesivir",
      "Remdesivir",
      "237",
      "2020-03-30",
      "2020-04-10",
      "https://clinicaltrials.gov/show/NCT04257656",
      "Journal Article",
      "2020-04-29",
      "https://doi.org/10.1016/S0140-6736(20)31022-9",
      "2020-04-27",
      "None"
    ],
    [
      "762",
      "NCT04276688",
      "ClinicalTrials.gov",
      "2020-02-11",
      "2020-02-10",
      "True",
      "University of Hong Kong",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Hong Kong",
      "Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",
      "",
      "Drug",
      "Lopinavir/ritonavir + Ribavirin + Interferon beta",
      "Lopinavir/ritonavir; Ribavirin; Interferon beta",
      "127",
      "2020-03-30",
      "2020-03-31",
      "https://clinicaltrials.gov/show/NCT04276688",
      "Journal Article",
      "2020-05-08",
      "https://doi.org/10.1016/S0140-6736(20)31042-4",
      "2020-04-27",
      "None"
    ],
    [
      "781",
      "NCT04336215",
      "ClinicalTrials.gov",
      "2020-04-02",
      "2020-04-07",
      "False",
      "Rutgers University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Rutgers COVID-19 Cohort Study",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "750",
      "2020-09-01",
      "2021-10-21",
      "https://clinicaltrials.gov/show/NCT04336215",
      "Pre-Print Article",
      "2020-04-24",
      "https://doi.org/10.1101/2020.04.20.20072470",
      "2020-04-27",
      "None"
    ],
    [
      "805",
      "NCT04345523",
      "ClinicalTrials.gov",
      "2020-04-02",
      "2020-04-03",
      "False",
      "Cristina Avenda\u00f1o-Sol\u00e1",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "Spain",
      "Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients",
      "ConPlas-19",
      "ATMP",
      "Plasma",
      "Plasma",
      "278",
      "2020-07-20",
      "2020-07-20",
      "https://clinicaltrials.gov/show/NCT04345523",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.26.20182444",
      "2020-04-27",
      "None"
    ],
    [
      "837",
      "NCT04351646",
      "ClinicalTrials.gov",
      "2020-04-07",
      "2020-04-15",
      "False",
      "St. George's, University of London",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "United Kingdom",
      "Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak)",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "500",
      "2022-04-15",
      "2022-04-15",
      "https://clinicaltrials.gov/show/NCT04351646",
      "Pre-Print Article",
      "2020-06-09",
      "https://doi.org/10.1101/2020.06.07.20124636",
      "2020-04-27",
      "None"
    ],
    [
      "895",
      "NCT04320017",
      "ClinicalTrials.gov",
      "2020-03-20",
      "2020-03-20",
      "False",
      "Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19",
      "JOCOVID",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "500",
      "2020-05-20",
      "2020-05-20",
      "https://clinicaltrials.gov/show/NCT04320017",
      "Pre-Print Article",
      "2020-05-08",
      "https://doi.org/10.1101/2020.05.04.20090118",
      "2020-05-04",
      "None"
    ],
    [
      "901",
      "NCT04331808",
      "ClinicalTrials.gov",
      "2020-03-31",
      "2020-03-30",
      "True",
      "Assistance Publique \u2013 H\u00f4pitaux de Paris",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "France",
      "CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)",
      "CORIMUNO-TOC",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "228",
      "2021-03-31",
      "2021-12-31",
      "https://clinicaltrials.gov/show/NCT04331808",
      "Journal Article",
      "2020-10-20",
      "https://doi.org/10.1001/jamainternmed.2020.6820",
      "2020-05-04",
      "None"
    ],
    [
      "913",
      "NCT04347993",
      "ClinicalTrials.gov",
      "2020-04-13",
      "2020-03-27",
      "True",
      "Hackensack Meridian Health",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "A Prospective \"Universal\" Observational Database for COVID-19",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "5000",
      "2020-04-21",
      "2020-04-21",
      "https://clinicaltrials.gov/show/NCT04347993",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.04.24.20077388\n\nhttps://doi.org/10.1101/2020.05.21.20109207",
      "2020-05-04",
      "None"
    ],
    [
      "1004",
      "ChiCTR2000032458",
      "ChiCTR",
      "2020-04-29",
      "2020-02-29",
      "True",
      "Department of Science and Technology of Guizhou Province",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "25",
      "Not Available",
      "Not Available",
      "http://www.chictr.org.cn/showproj.aspx?proj=52779",
      "Pre-Print Article",
      "2020-05-26",
      "https://doi.org/10.1101/2020.05.21.20074682",
      "2020-05-04",
      "None"
    ],
    [
      "1020",
      "NCT04329923",
      "ClinicalTrials.gov",
      "2020-03-30",
      "2020-04-09",
      "False",
      "Ravi Amaravadi, MD",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "United States",
      "The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)",
      "PATCH",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "400",
      "2021-04-01",
      "2021-12-01",
      "https://clinicaltrials.gov/show/NCT04329923",
      "Journal Article",
      "2020-09-30",
      "https://doi.org/10.1001/jamainternmed.2020.6319",
      "2020-05-11",
      "None"
    ],
    [
      "1040",
      "NCT04366206",
      "ClinicalTrials.gov",
      "2020-04-19",
      "2020-03-14",
      "True",
      "Centre Hospitalier Intercommunal Robert Ballanger",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "143",
      "2020-07-31",
      "2020-07-31",
      "https://clinicaltrials.gov/show/NCT04366206",
      "Pre-Print Article",
      "2020-06-09",
      "https://doi.org/10.1101/2020.06.06.20122341",
      "2020-05-11",
      "None"
    ],
    [
      "1070",
      "NCT04369690",
      "ClinicalTrials.gov",
      "2020-04-20",
      "2020-04-03",
      "True",
      "University of Ottawa",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Canada",
      "The Psychological, Social, and Economic Impacts of COVID-19",
      "C19Survey",
      "Other (psych)",
      "No Intervention",
      "No Intervention",
      "1000",
      "2021-04-03",
      "2021-04-03",
      "https://clinicaltrials.gov/show/NCT04369690",
      "Pre-Print Article",
      "2020-06-30",
      "https://doi.org/10.1101/2020.06.29.20142638",
      "2020-05-11",
      "None"
    ],
    [
      "1083",
      "ChiCTR2000032770",
      "ChiCTR",
      "2020-05-10",
      "2020-01-29",
      "True",
      "Department of Science and Technology of Guizhou Province",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "52",
      "Not Available",
      "2020-03-31",
      "http://www.chictr.org.cn/showproj.aspx?proj=53228",
      "Pre-Print Article",
      "2020-05-20",
      "https://doi.org/10.1101/2020.05.16.20103796",
      "2020-05-11",
      "None"
    ],
    [
      "1108",
      "EUCTR2020-001934-37-ES",
      "EU Clinical Trials Register",
      "2020-05-08",
      "2020-05-07",
      "True",
      "Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla (IDIVAL)",
      "Authorised",
      "Phase 4",
      "Interventional",
      "Spain",
      "USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION",
      "",
      "Drug",
      "Corticosteroids",
      "Methylprednisolone",
      "200",
      "Not Available",
      "Not Available",
      "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37",
      "Pre-Print Article",
      "2020-06-18",
      "https://doi.org/10.1101/2020.06.17.20133579",
      "2020-05-11",
      "None"
    ],
    [
      "1114",
      "NCT04337047",
      "ClinicalTrials.gov",
      "2020-04-03",
      "2020-03-31",
      "True",
      "Wefight",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Distress in Crisis Situations During COVID-19",
      "",
      "Other (psych)",
      "No Intervention",
      "No Intervention",
      "2000",
      "2020-04-30",
      "2020-05-03",
      "https://clinicaltrials.gov/show/NCT04337047",
      "Pre-Print Article",
      "2020-05-15",
      "https://doi.org/10.1101/2020.05.10.20093161",
      "2020-05-14",
      "None"
    ],
    [
      "1147",
      "NCT04374071",
      "ClinicalTrials.gov",
      "2020-04-30",
      "2020-03-12",
      "True",
      "Henry Ford Health System",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Early Short Course Corticosteroids in COVID-19",
      "",
      "Drug",
      "Corticosteroids",
      "Methylprednisolone",
      "250",
      "2020-03-27",
      "2020-04-30",
      "https://clinicaltrials.gov/show/NCT04374071",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.05.04.20074609\n\nhttps://doi.org/10.1101/2020.05.06.20076687",
      "2020-05-14",
      "None"
    ],
    [
      "1149",
      "NCT04374695",
      "ClinicalTrials.gov",
      "2020-05-03",
      "2020-05-01",
      "True",
      "Versailles Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "No Country Given",
      "Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",
      "COVHYP",
      "Drug",
      "ACE inhibitors or ARBs",
      "ACE inhibitors; ARBs",
      "700",
      "2020-06-01",
      "2020-07-01",
      "https://clinicaltrials.gov/show/NCT04374695",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.30.20182451",
      "2020-05-14",
      "None"
    ],
    [
      "1155",
      "NCT04326790",
      "ClinicalTrials.gov",
      "2020-03-26",
      "2020-04-03",
      "True",
      "National and Kapodistrian University of Athens",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "Gibraltar",
      "The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention",
      "GRECCO-19",
      "Drug",
      "Colchicine",
      "Colchicine",
      "180",
      "2020-08-31",
      "2020-09-30",
      "https://clinicaltrials.gov/show/NCT04326790",
      "Journal Article",
      "2020-06-24",
      "https://doi.org/10.1001/jamanetworkopen.2020.13136",
      "2020-05-18",
      "EUCTR2020-001455-40"
    ],
    [
      "1188",
      "NCT04375774",
      "ClinicalTrials.gov",
      "2020-04-17",
      "2020-05-01",
      "False",
      "University Clinic, UCLouvain",
      "Recruiting",
      "Not Applicable",
      "Interventional",
      "Belgium",
      "Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE)",
      "VADER",
      "Other (device)",
      "Masks",
      "Masks",
      "10",
      "2020-05-20",
      "2020-05-20",
      "https://clinicaltrials.gov/show/NCT04375774",
      "Pre-Print Article",
      "2020-05-26",
      "https://doi.org/10.1101/2020.05.23.20111054",
      "2020-05-18",
      "None"
    ],
    [
      "1211",
      "NCT04379297",
      "ClinicalTrials.gov",
      "2020-05-06",
      "2020-04-10",
      "True",
      "Luxembourg Institute of Health",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Luxembourg",
      "COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE)",
      "CON-VINCE",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "1800",
      "2021-05-28",
      "2021-12-31",
      "https://clinicaltrials.gov/show/NCT04379297",
      "Pre-Print Article",
      "2020-05-18",
      "https://doi.org/10.1101/2020.05.11.20092916",
      "2020-05-18",
      "None"
    ],
    [
      "1250",
      "IRCT20200328046886N1",
      "IRCT",
      "2020-04-12",
      "2020-03-05",
      "True",
      "Mazandaran University of Medical Sciences",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Iran",
      "The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients",
      "",
      "Drug",
      "Daclatasvir/sofosbuvir",
      "Daclatasvir/sofosbuvir",
      "48",
      "Not Available",
      "2020-05-04",
      "http://en.irct.ir/trial/46885",
      "Journal Article",
      "2020-08-19",
      "https://doi.org/10.1093/jac/dkaa332",
      "2020-05-18",
      "None"
    ],
    [
      "1414",
      "NCT04364698",
      "ClinicalTrials.gov",
      "2020-04-24",
      "2020-05-07",
      "False",
      "Assistance Publique \u2013 H\u00f4pitaux de Paris",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Observational Cohort of COVID-19 Patients at Raymond-Poincare",
      "COVID-RPC",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "500",
      "2020-06-20",
      "2020-06-20",
      "https://clinicaltrials.gov/show/NCT04364698",
      "Pre-Print Article",
      "2020-05-11",
      "https://doi.org/10.1101/2020.05.05.20088757",
      "2020-05-25",
      "None"
    ],
    [
      "1422",
      "NCT04380896",
      "ClinicalTrials.gov",
      "2020-05-04",
      "2020-04-27",
      "True",
      "Great Ormond Street Hospital for Children NHS Foundation Trust",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United Kingdom",
      "COVID-19 Staff Testing of Antibody Responses Study (Co-Stars)",
      "Co-Stars",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "1000",
      "2026-07-27",
      "2026-07-27",
      "https://clinicaltrials.gov/show/NCT04380896",
      "Pre-Print Article",
      "2020-07-22",
      "https://doi.org/10.1101/2020.07.16.20155663",
      "2020-05-25",
      "None"
    ],
    [
      "1474",
      "ChiCTR2000033056",
      "ChiCTR",
      "2020-05-19",
      "2020-01-29",
      "True",
      "Guizhou Provincial Jiangjunshan Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Convalescent Plasma in the treatment of 6 COVID-19 Patients",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "6",
      "Not Available",
      "2020-04-30",
      "http://www.chictr.org.cn/showproj.aspx?proj=53859",
      "Pre-Print Article",
      "2020-05-26",
      "https://doi.org/10.1101/2020.05.21.201095122",
      "2020-05-25",
      "None"
    ],
    [
      "1487",
      "NCT04313127",
      "ClinicalTrials.gov",
      "2020-03-15",
      "2020-03-16",
      "False",
      "CanSino Biologics Inc.",
      "Not Recruiting",
      "Phase 1",
      "Interventional",
      "China",
      "Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults",
      "CTCOVID-19",
      "ATMP",
      "Adenovirus vector",
      "Adenovirus vector",
      "108",
      "2020-12-30",
      "2022-12-20",
      "https://clinicaltrials.gov/show/NCT04313127",
      "Journal Article",
      "2020-11-05",
      "https://doi.org/10.1016/S0140-6736(20)31208-3",
      "2020-05-28",
      "None"
    ],
    [
      "1488",
      "NCT04326387",
      "ClinicalTrials.gov",
      "2020-03-26",
      "2020-04-06",
      "False",
      "University of Cambridge",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United Kingdom",
      "Evaluation of Novel Diagnostic Tests for COVID-19",
      "COVIDx",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "200",
      "2021-04-07",
      "2021-10-07",
      "https://clinicaltrials.gov/show/NCT04326387",
      "Pre-Print Article",
      "2020-06-02",
      "https://doi.org/10.1101/2020.05.31.20114520",
      "2020-05-28",
      "None"
    ],
    [
      "1493",
      "NCT04342182",
      "ClinicalTrials.gov",
      "2020-03-31",
      "2020-04-08",
      "False",
      "Erasmus Medical Center",
      "Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Netherlands",
      "Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)",
      "ConCoVid-19",
      "ATMP",
      "Plasma",
      "Plasma",
      "426",
      "2021-07-01",
      "2021-07-31",
      "https://clinicaltrials.gov/show/NCT04342182",
      "Pre-Print Article",
      "2020-07-03",
      "https://doi.org/10.1101/2020.07.01.20139857",
      "2020-05-28",
      "None"
    ],
    [
      "1495",
      "NCT04352842",
      "ClinicalTrials.gov",
      "2020-04-16",
      "2020-01-21",
      "True",
      "RenJi Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "China",
      "Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19)",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "51",
      "2020-04-08",
      "2020-04-08",
      "https://clinicaltrials.gov/show/NCT04352842",
      "Pre-Print Article",
      "2020-05-18",
      "https://doi.org/10.1101/2020.05.12.20095885",
      "2020-05-28",
      "None"
    ],
    [
      "1515",
      "NCT04389645",
      "ClinicalTrials.gov",
      "2020-05-13",
      "2020-04-07",
      "True",
      "MeMed Diagnostics Ltd.",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Israel",
      "Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "52",
      "2020-05-12",
      "2020-05-12",
      "https://clinicaltrials.gov/show/NCT04389645",
      "Pre-Print Article",
      "2020-07-22",
      "https://doi.org/10.1101/2020.07.21.20158782",
      "2020-05-28",
      "None"
    ],
    [
      "1598",
      "ChiCTR2000033372",
      "ChiCTR",
      "2020-05-29",
      "2020-03-12",
      "True",
      "Shandong University Qilu Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "China",
      "Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study",
      "",
      "Drug",
      "Leflunomide",
      "Leflunomide",
      "30",
      "Not Available",
      "2020-05-17",
      "http://www.chictr.org.cn/showproj.aspx?proj=54408",
      "Pre-Print Article",
      "2020-06-02",
      "https://doi.org/10.1101/2020.05.29.20114223",
      "2020-06-01",
      "None"
    ],
    [
      "1672",
      "NCT04321421",
      "ClinicalTrials.gov",
      "2020-03-23",
      "2020-03-17",
      "True",
      "Foundation IRCCS San Matteo Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "Italy",
      "Hyperimmune Plasma for Critical Patients With COVID-19",
      "COV19-PLASMA",
      "ATMP",
      "Plasma",
      "Plasma",
      "49",
      "2020-04-28",
      "2020-05-07",
      "https://clinicaltrials.gov/show/NCT04321421",
      "Pre-Print Article",
      "2020-05-29",
      "https://doi.org/10.1101/2020.05.26.20113373",
      "2020-06-08",
      "None"
    ],
    [
      "1740",
      "NCT04322123",
      "ClinicalTrials.gov",
      "2020-03-24",
      "2020-04-01",
      "True",
      "Hospital do Cora\u00e7\u00e3o",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Brazil",
      "Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)",
      "Coalition-I",
      "Drug",
      "Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine",
      "Hydroxychloroquine; azithromycin",
      "630",
      "2020-08-30",
      "2020-08-30",
      "https://clinicaltrials.gov/show/NCT04322123",
      "Journal Article",
      "2020-07-23",
      "https://doi.org/10.1056/NEJMoa2019014",
      "2020-06-11",
      "RBR-9d8z6m"
    ],
    [
      "1741",
      "NCT04322188",
      "ClinicalTrials.gov",
      "2020-03-24",
      "2020-03-19",
      "True",
      "A.O. Ospedale Papa Giovanni XXIII",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Italy",
      "An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications",
      "SISCO",
      "Drug",
      "Siltuximab",
      "Siltuximab",
      "220",
      "2020-05-08",
      "2020-05-08",
      "https://clinicaltrials.gov/show/NCT04322188",
      "Pre-Print Article",
      "2020-04-03",
      "https://doi.org/10.1101/2020.04.01.20048561",
      "2020-06-11",
      "None"
    ],
    [
      "1869",
      "IRCT20200128046294N2",
      "IRCT",
      "2020-03-14",
      "2020-03-26",
      "False",
      "Digestive Disease Research Institute",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Iran",
      "Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19)",
      "",
      "Drug",
      "Sofosbuvir + Daclatasvir",
      "Sofosbuvir; Daclatasvir",
      "70",
      "Not Available",
      "2020-05-18",
      "http://en.irct.ir/trial/46463",
      "Journal Article",
      "2020-08-18",
      "https://doi.org/10.1093/jac/dkaa334",
      "2020-06-15",
      "None"
    ],
    [
      "1979",
      "NCT04370223",
      "ClinicalTrials.gov",
      "2020-04-27",
      "2020-05-25",
      "False",
      "Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona Dr. Josep Trueta",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Spain",
      "Ozone Auto-hemotherapy for COVID-19 Pneumonia",
      "COVID-OZONE",
      "Drug",
      "Ozone",
      "Ozone",
      "208",
      "2020-10-25",
      "2020-12-25",
      "https://clinicaltrials.gov/show/NCT04370223",
      "Pre-Print Article",
      "2020-06-05",
      "https://doi.org/10.1101/2020.06.03.20117994",
      "2020-06-18",
      "None"
    ],
    [
      "2023",
      "NCT04351503",
      "ClinicalTrials.gov",
      "2020-04-15",
      "2020-04-09",
      "True",
      "University Hospital, Basel",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Switzerland",
      "A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "10000",
      "2020-04-22",
      "2020-04-22",
      "https://clinicaltrials.gov/show/NCT04351503",
      "Journal Article",
      "2020-07-08",
      "http://doi.org/10.1128/AAC.01177-20",
      "2020-06-22",
      "None"
    ],
    [
      "2118",
      "NCT04347408",
      "ClinicalTrials.gov",
      "2020-04-07",
      "2020-05-06",
      "False",
      "Queen's University, Belfast",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United Kingdom",
      "Seroprevalence of SARS-Cov-2 Antibodies in Children",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "1000",
      "2020-12-13",
      "2020-12-13",
      "https://clinicaltrials.gov/show/NCT04347408",
      "Pre-Print Article",
      "2020-09-02",
      "https://doi.org/10.1101/2020.08.31.20183095",
      "2020-06-25",
      "None"
    ],
    [
      "2127",
      "NCT04397900",
      "ClinicalTrials.gov",
      "2020-05-19",
      "2020-04-09",
      "True",
      "TScan Therapeutics, Inc.",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "80",
      "2020-07-01",
      "2020-07-20",
      "https://clinicaltrials.gov/show/NCT04397900",
      "Pre-Print Article",
      "2020-07-27",
      "https://doi.org/10.1101/2020.07.24.20161653",
      "2020-06-25",
      "None"
    ],
    [
      "2131",
      "NCT04413071",
      "ClinicalTrials.gov",
      "2020-05-23",
      "2020-05-25",
      "False",
      "AORTICA Group",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Spain",
      "Cardiac COVID-19 Health Care Workers",
      "CCC",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "142",
      "2020-06-12",
      "2020-06-12",
      "https://clinicaltrials.gov/show/NCT04413071",
      "Pre-Print Article",
      "2020-07-14",
      "https://doi.org/10.1101/2020.07.12.20151316",
      "2020-06-25",
      "None"
    ],
    [
      "2160",
      "NCT04366791",
      "ClinicalTrials.gov",
      "2020-04-24",
      "2020-04-23",
      "True",
      "Emory University",
      "Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "United States",
      "Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19",
      "RESCUE 1-19",
      "Other",
      "Radiation",
      "Radiation",
      "10",
      "2020-10-23",
      "2020-10-23",
      "https://clinicaltrials.gov/show/NCT04366791",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.06.03.20116988\n\nhttps://doi.org/10.1101/2020.07.11.20147793",
      "2020-06-29",
      "None"
    ],
    [
      "2184",
      "NCT04434248",
      "ClinicalTrials.gov",
      "2020-06-13",
      "2020-04-23",
      "True",
      "Chromis LLC",
      "Not Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Russian Federation",
      "An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19",
      "",
      "Drug",
      "Favipiravir",
      "Favipiravir",
      "330",
      "2020-07-20",
      "2020-07-20",
      "https://clinicaltrials.gov/show/NCT04434248",
      "Journal Article",
      "2020-08-09",
      "https://doi.org/10.1101/2020.07.26.20154724",
      "2020-06-29",
      "None"
    ],
    [
      "2196",
      "NCT04435808",
      "ClinicalTrials.gov",
      "2020-06-04",
      "2020-04-14",
      "True",
      "University of New Mexico",
      "Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "United States",
      "Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19",
      "",
      "Drug (Chemoprophylaxis)",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "350",
      "2020-07-15",
      "2020-07-15",
      "https://clinicaltrials.gov/show/NCT04435808",
      "Registry Results",
      "2020-11-16",
      "https://clinicaltrials.gov/ct2/show/results/NCT04435808",
      "2020-06-29",
      "None"
    ],
    [
      "2220",
      "NCT04318366",
      "ClinicalTrials.gov",
      "2020-03-19",
      "2020-03-19",
      "False",
      "Universita Vita-Salute San Raffaele",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Italy",
      "COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",
      "COVID-BioB",
      "Prognosis",
      "No Intervention",
      "No Intervention",
      "1000",
      "2022-03-19",
      "2022-03-19",
      "https://clinicaltrials.gov/show/NCT04318366",
      "Journal Article",
      "2020-05-07",
      "https://doi.org/10.1016/S2665-9913(20)30127-2",
      "2020-07-02",
      "None"
    ],
    [
      "2221",
      "NCT04346355",
      "ClinicalTrials.gov",
      "2020-04-12",
      "2020-03-31",
      "True",
      "Azienda Unita Sanitaria Locale Reggio Emilia",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Italy",
      "Efficacy of Early Administration of Tocilizumab in COVID-19 Patients",
      "",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "126",
      "2020-06-06",
      "2020-06-06",
      "https://clinicaltrials.gov/show/NCT04346355",
      "Journal Article",
      "2020-10-20",
      "https://doi.org/10.1001/jamainternmed.2020.6615",
      "2020-07-02",
      "EUCTR2020-001386-37"
    ],
    [
      "2275",
      "NCT04323592",
      "ClinicalTrials.gov",
      "2020-03-19",
      "2020-03-23",
      "False",
      "University of Trieste",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Italy",
      "Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome",
      "MP-C19",
      "Drug",
      "Corticosteroids",
      "Methylprednisolone",
      "173",
      "2020-05-10",
      "2020-05-10",
      "https://clinicaltrials.gov/show/NCT04323592",
      "Registry Results",
      "2020-06-04",
      "https://clinicaltrials.gov/ct2/show/results/NCT04323592",
      "2020-07-06",
      "None"
    ],
    [
      "2276",
      "NCT04323592",
      "ClinicalTrials.gov",
      "2020-03-19",
      "2020-03-23",
      "False",
      "University of Trieste",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Italy",
      "Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome",
      "MP-C19",
      "Drug",
      "Corticosteroids",
      "Methylprednisolone",
      "173",
      "2020-05-10",
      "2020-05-10",
      "https://clinicaltrials.gov/show/NCT04323592",
      "Pre-Print Article",
      "2020-06-20",
      "https://doi.org/10.1101/2020.06.17.20134031",
      "2020-07-06",
      "None"
    ],
    [
      "2330",
      "NCT04445506",
      "ClinicalTrials.gov",
      "2020-06-19",
      "2020-04-01",
      "True",
      "The Miriam Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Short Term Corticosteroids in SARS-CoV2 Patients",
      "",
      "Drug",
      "Corticosteroids",
      "Dexamethasone",
      "50",
      "2020-05-31",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04445506",
      "Pre-Print Article",
      "2020-06-23",
      "https://doi.org/10.1101/2020.06.19.20109173",
      "2020-07-06",
      "None"
    ],
    [
      "2351",
      "NCT04304053",
      "ClinicalTrials.gov",
      "2020-03-05",
      "2020-03-18",
      "True",
      "Fundaci\u00f3 Lluita contra la SIDA",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Spain",
      "Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention",
      "HCQ4COV19",
      "Drug (Chemoprophylaxis)",
      "Darunavir + cobicistat + hydroxychloroquine",
      "Darunavir; cobicistat; hydroxychloroquine",
      "2300",
      "2020-06-15",
      "2020-06-15",
      "https://clinicaltrials.gov/show/NCT04304053",
      "Journal Article",
      "2020-07-16",
      "https://doi.org/10.1093/cid/ciaa1009",
      "2020-07-09",
      "EUCTR2020-001031-27"
    ],
    [
      "2381",
      "NCT04252885",
      "ClinicalTrials.gov",
      "2020-01-30",
      "2020-01-28",
      "True",
      "Guangzhou 8th People's Hospital",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection",
      "ELACOI",
      "Drug",
      "Lopinavir/ritonavir vs. umifenovir",
      "Lopinavir/ritonavir; Umifenovir",
      "86",
      "2020-04-30",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04252885",
      "Pre-Print Article",
      "2020-03-23",
      "https://doi.org/10.1101/2020.03.19.20038984",
      "2020-07-13",
      "None"
    ],
    [
      "2382",
      "NCT04252885",
      "ClinicalTrials.gov",
      "2020-01-30",
      "2020-01-28",
      "True",
      "Guangzhou 8th People's Hospital",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "China",
      "The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection",
      "ELACOI",
      "Drug",
      "Lopinavir/ritonavir vs. umifenovir",
      "Lopinavir/ritonavir; Umifenovir",
      "86",
      "2020-04-30",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04252885",
      "Journal Article",
      "2020-05-19",
      "https://doi.org/10.1016/j.medj.2020.04.001",
      "2020-07-13",
      "None"
    ],
    [
      "2384",
      "NCT04321278",
      "ClinicalTrials.gov",
      "2020-03-23",
      "2020-03-28",
      "False",
      "Hospital Israelita Albert Einstein",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Brazil",
      "Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)",
      "",
      "Drug",
      "Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine",
      "Hydroxychloroquine; azithromycin",
      "440",
      "2020-06-14",
      "2020-06-14",
      "https://clinicaltrials.gov/show/NCT04321278",
      "Journal Article",
      "2020-09-05",
      "https://doi.org/10.1016/S0140-6736(20)31862-6",
      "2020-07-13",
      "None"
    ],
    [
      "2385",
      "NCT04343729",
      "ClinicalTrials.gov",
      "2020-04-09",
      "2020-04-18",
      "False",
      "Funda\u00e7\u00e3o de Medicina Tropical Dr. Heitor Vieira Dourado",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Brazil",
      "Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19",
      "MetCOVID",
      "Drug",
      "Corticosteroids",
      "Methylprednisolone",
      "416",
      "2020-06-16",
      "2020-09-20",
      "https://clinicaltrials.gov/show/NCT04343729",
      "Journal Article",
      "2020-08-12",
      "https://doi.org/10.1093/cid/ciaa1177",
      "2020-07-13",
      "None"
    ],
    [
      "2419",
      "NCT04452422",
      "ClinicalTrials.gov",
      "2020-06-23",
      "2020-06-23",
      "False",
      "University Hospital, Strasbourg",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology",
      "VT-Covid-19",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "30",
      "2020-09-23",
      "2020-09-23",
      "https://clinicaltrials.gov/show/NCT04452422",
      "Pre-Print Article",
      "2020-09-05",
      "https://doi.org/10.1101/2020.09.03.20187344",
      "2020-07-13",
      "None"
    ],
    [
      "2507",
      "NCT04351659",
      "ClinicalTrials.gov",
      "2020-04-16",
      "2020-04-14",
      "True",
      "KK Women's and Children's Hospital",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Singapore",
      "Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "8",
      "2020-08-20",
      "2020-08-20",
      "https://clinicaltrials.gov/show/NCT04351659",
      "Pre-Print Article",
      "2020-04-30",
      "https://doi.org/10.1101/2020.04.24.20077487",
      "2020-07-16",
      "None"
    ],
    [
      "2537",
      "NCT04318431",
      "ClinicalTrials.gov",
      "2020-03-20",
      "2020-04-14",
      "False",
      "Centre Hospitalier Intercommunal Creteil",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "France",
      "Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children",
      "COVILLE",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "605",
      "2020-05-12",
      "2020-06-01",
      "https://clinicaltrials.gov/show/NCT04318431",
      "Pre-Print Article",
      "2020-06-14",
      "https://doi.org/10.1101/2020.06.12.20129221",
      "2020-07-20",
      "None"
    ],
    [
      "2548",
      "NCT04347850",
      "ClinicalTrials.gov",
      "2020-04-09",
      "2020-02-01",
      "True",
      "University Hospital, Montpellier",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19)",
      "COVIDoth\u00e8que",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "500",
      "2022-12-01",
      "2022-12-30",
      "https://clinicaltrials.gov/show/NCT04347850",
      "Pre-Print Article",
      "2020-05-12",
      "https://doi.org/10.1101/2020.05.04.20090027",
      "2020-07-20",
      "None"
    ],
    [
      "2587",
      "NCT04457388",
      "ClinicalTrials.gov",
      "2020-06-30",
      "2020-03-25",
      "True",
      "Aarogyam UK",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "United Kingdom",
      "Tele-Yoga Therapy for Chronic Pain",
      "",
      "Traditional Medicine (Other)",
      "Traditional Medicine",
      "Traditional Medicine",
      "18",
      "2020-06-15",
      "2020-06-15",
      "https://clinicaltrials.gov/show/NCT04457388",
      "Pre-Print Article",
      "2020-07-17",
      "https://doi.org/10.1101/2020.07.16.20154229",
      "2020-07-20",
      "None"
    ],
    [
      "2599",
      "NCT04462393",
      "ClinicalTrials.gov",
      "2020-07-06",
      "2020-03-06",
      "True",
      "Linkoeping University",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Sweden",
      "Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "1563",
      "2020-05-06",
      "2020-05-06",
      "https://clinicaltrials.gov/show/NCT04462393",
      "Pre-Print Article",
      "2020-08-07",
      "https://doi.org/10.1101/2020.08.06.20169599",
      "2020-07-20",
      "None"
    ],
    [
      "2622",
      "NCT04468646",
      "ClinicalTrials.gov",
      "2020-07-07",
      "2020-06-15",
      "True",
      "Dr. Fridoon Jawad Ahmad",
      "Recruiting",
      "Phase 3",
      "Interventional",
      "Pakistan",
      "To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients",
      "",
      "Drug",
      "NK-1R antagonist",
      "NK-1R antagonist",
      "100",
      "2020-07-15",
      "2020-08-30",
      "https://clinicaltrials.gov/show/NCT04468646",
      "Pre-Print Article",
      "2020-08-04",
      "https://doi.org/10.1101/2020.08.01.20166678",
      "2020-07-20",
      "None"
    ],
    [
      "2644",
      "NCT04283461",
      "ClinicalTrials.gov",
      "2020-02-21",
      "2020-03-16",
      "False",
      "National Institute of Allergy and Infectious Diseases (NIAID)",
      "Not Recruiting",
      "Phase 1",
      "Interventional",
      "United States",
      "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)",
      "",
      "ATMP",
      "Vaccine",
      "Vaccine",
      "120",
      "2021-11-22",
      "2021-11-22",
      "https://clinicaltrials.gov/show/NCT04283461",
      "Journal Article",
      "2020-07-14",
      "https://doi.org/10.1056/NEJMoa2022483",
      "2020-07-27",
      "None"
    ],
    [
      "2645",
      "NCT04308668",
      "ClinicalTrials.gov",
      "2020-03-11",
      "2020-03-17",
      "False",
      "University of Minnesota",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "United States, Canada",
      "Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2",
      "COVID-19 PEP",
      "Drug (Chemoprophylaxis)",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "1309",
      "2020-05-20",
      "2020-05-20",
      "https://clinicaltrials.gov/show/NCT04308668",
      "Journal Article",
      "2020-06-03",
      "https://doi.org/10.1056/NEJMoa2016638",
      "2020-07-27",
      "None"
    ],
    [
      "2679",
      "NCT04410159",
      "ClinicalTrials.gov",
      "2020-05-27",
      "2020-06-22",
      "False",
      "Universiti Sains Islam Malaysia",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Malaysia",
      "Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients",
      "GARGLES",
      "Drug",
      "Povidone Iodine vs. Essential Oil",
      "Povidone Iodine; Essential Oil",
      "20",
      "2020-06-29",
      "2020-07-06",
      "https://clinicaltrials.gov/show/NCT04410159",
      "Registry Results",
      "2020-07-21",
      "https://clinicaltrials.gov/ct2/show/results/NCT04410159",
      "2020-07-27",
      "None"
    ],
    [
      "2713",
      "NCT04472078",
      "ClinicalTrials.gov",
      "2020-07-12",
      "2020-06-10",
      "True",
      "Hospital Italiano de Buenos Aires",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Argentina",
      "Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "873",
      "2020-06-26",
      "2020-07-18",
      "https://clinicaltrials.gov/show/NCT04472078",
      "Pre-Print Article",
      "2020-07-16",
      "https://doi.org/10.1101/2020.07.14.20153858",
      "2020-07-27",
      "None"
    ],
    [
      "2776",
      "NCT04292730",
      "ClinicalTrials.gov",
      "2020-02-28",
      "2020-03-15",
      "True",
      "Gilead Sciences",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "United States, Germany, Spain, Netherlands, Sweden, Taiwan, Iran, United Kingdom, Singapore, Japan, Switzerland, South Korea, Italy, Hong Kong, France, China",
      "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment",
      "",
      "Drug",
      "Remdesivir",
      "Remdesivir",
      "1113",
      "2020-04-29",
      "2020-06-26",
      "https://clinicaltrials.gov/show/NCT04292730",
      "Journal Article",
      "2020-08-21",
      "https://doi.org/10.1001/jama.2020.16349",
      "2020-08-03",
      "EUCTR2020-000842-32"
    ],
    [
      "2777",
      "NCT04292899",
      "ClinicalTrials.gov",
      "2020-02-28",
      "2020-03-06",
      "True",
      "Gilead Sciences",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "United States, Germany, Spain, Netherlands, Sweden, Taiwan, United Kingdom, Singapore, Japan, Switzerland, South Korea, Italy, Hong Kong, France, China",
      "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Severe Coronavirus Disease (COVID-19)",
      "",
      "Drug",
      "Remdesivir",
      "Remdesivir",
      "4891",
      "2020-04-09",
      "2020-06-30",
      "https://clinicaltrials.gov/show/NCT04292899",
      "Journal Article",
      "2020-05-27",
      "https://doi.org/10.1056/NEJMoa2015301",
      "2020-08-03",
      "EUCTR2020-000841-15"
    ],
    [
      "2849",
      "NCT04480398",
      "ClinicalTrials.gov",
      "2020-07-18",
      "2020-05-12",
      "True",
      "Aarogyam UK",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "India",
      "Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients",
      "",
      "Traditional Medicine (Drug)",
      "Traditional Medicine",
      "Traditional Medicine",
      "91",
      "2020-06-15",
      "2020-07-03",
      "https://clinicaltrials.gov/show/NCT04480398",
      "Pre-Print Article",
      "2020-07-29",
      "https://doi.org/10.1101/2020.07.23.20160424",
      "2020-08-03",
      "None"
    ],
    [
      "2893",
      "NCT04488588",
      "ClinicalTrials.gov",
      "2020-07-24",
      "2020-03-15",
      "True",
      "Assiut University",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Egypt",
      "Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "1064",
      "2020-05-01",
      "2020-07-01",
      "https://clinicaltrials.gov/show/NCT04488588",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.26.20180992",
      "2020-08-03",
      "None"
    ],
    [
      "2912",
      "NCT04331795",
      "ClinicalTrials.gov",
      "2020-04-01",
      "2020-04-04",
      "False",
      "University of Chicago",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "United States",
      "Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",
      "COVIDOSE",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "32",
      "2020-06-05",
      "2020-06-05",
      "https://clinicaltrials.gov/show/NCT04331795",
      "Pre-Print Article",
      "2020-07-26",
      "https://doi.org/10.1101/2020.07.20.20157503",
      "2020-08-10",
      "None"
    ],
    [
      "2916",
      "NCT04337541",
      "ClinicalTrials.gov",
      "2020-04-02",
      "2020-04-02",
      "False",
      "Rigshospitalet, Denmark",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "Denmark",
      "Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System",
      "",
      "Other (device)",
      "Masks",
      "Masks",
      "6000",
      "2020-06-02",
      "2020-06-02",
      "https://clinicaltrials.gov/show/NCT04337541",
      "Journal Article",
      "2020-11-18",
      "https://doi.org/10.7326/M20-6817",
      "2020-08-10",
      "None"
    ],
    [
      "2924",
      "NCT04352608",
      "ClinicalTrials.gov",
      "2020-04-14",
      "2020-04-16",
      "False",
      "Sinovac Research and Development Co., Ltd.",
      "Not Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "China",
      "Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)",
      "",
      "ATMP",
      "Vaccine",
      "Vaccine",
      "744",
      "2020-07-10",
      "2020-12-13",
      "https://clinicaltrials.gov/show/NCT04352608",
      "Pre-Print Article",
      "2020-08-10",
      "https://doi.org/10.1101/2020.07.31.20161216",
      "2020-08-10",
      "None"
    ],
    [
      "2945",
      "NCT04384380",
      "ClinicalTrials.gov",
      "2020-04-07",
      "2020-04-01",
      "True",
      "Taoyuan General Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "Taiwan",
      "Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19",
      "",
      "Drug",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "33",
      "2020-05-31",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04384380",
      "Pre-Print Article",
      "2020-07-10",
      "https://doi.org/10.1101/2020.07.08.20148841",
      "2020-08-10",
      "None"
    ],
    [
      "3069",
      "NCT04327401",
      "ClinicalTrials.gov",
      "2020-03-26",
      "2020-04-13",
      "False",
      "Hospital S\u00edrio-Liban\u00eas",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Brazil",
      "COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III",
      "CoDEX",
      "Drug",
      "Dexamethasone",
      "Dexamethasone",
      "299",
      "2020-07-22",
      "2020-07-22",
      "https://clinicaltrials.gov/show/NCT04327401",
      "Journal Article",
      "2020-09-02",
      "https://doi.org/10.1001/jama.2020.17021",
      "2020-08-17",
      "None"
    ],
    [
      "3074",
      "NCT04355936",
      "ClinicalTrials.gov",
      "2020-04-17",
      "2020-05-19",
      "False",
      "Laboratorio Elea",
      "Recruiting",
      "Phase 4",
      "Interventional",
      "Argentina",
      "Telmisartan for Treatment of COVID-19 Patients",
      "",
      "Drug",
      "Telmisartan",
      "Telmisartan",
      "400",
      "2020-10-01",
      "2020-10-01",
      "https://clinicaltrials.gov/show/NCT04355936",
      "Pre-Print Article",
      "2020-08-11",
      "https://doi.org/10.1101/2020.08.04.20167205",
      "2020-08-17",
      "None"
    ],
    [
      "3100",
      "NCT04425863",
      "ClinicalTrials.gov",
      "2020-06-08",
      "2020-05-01",
      "True",
      "Eurnekian Public Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Argentina",
      "IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19",
      "",
      "Drug",
      "Ivermectin, Aspirin, Dexamethasone, Enoxaparin",
      "Ivermectin; Aspirin; Dexamethasone; Enoxaparin",
      "100",
      "2020-08-30",
      "2020-08-30",
      "https://clinicaltrials.gov/show/NCT04425863",
      "Registry Results",
      "2020-10-19",
      "https://clinicaltrials.gov/ct2/show/results/NCT04425863",
      "2020-08-17",
      "None"
    ],
    [
      "3211",
      "KCT0005226",
      "CRIS",
      "2020-07-13",
      "2020-03-23",
      "True",
      "Yonsei University Health System, Gangnam Severance Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "South Korea",
      "Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "293",
      "2020-04-24",
      "2020-04-27",
      "http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16997",
      "Journal Article",
      "2020-06-23",
      "https://doi.org/10.3390/jcm9061959",
      "2020-08-18",
      "None"
    ],
    [
      "3354",
      "NCT04422561",
      "ClinicalTrials.gov",
      "2020-06-06",
      "2020-05-31",
      "True",
      "Zagazig University",
      "Not Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Egypt",
      "Prophylactic Ivermectin in COVID-19 Contacts",
      "",
      "Drug (Chemoprophylaxis)",
      "Ivermectin",
      "Ivermectin",
      "340",
      "2020-07-14",
      "2020-07-27",
      "https://clinicaltrials.gov/show/NCT04422561",
      "Registry Results",
      "2020-08-27",
      "https://clinicaltrials.gov/ct2/show/results/NCT04422561",
      "2020-08-31",
      "None"
    ],
    [
      "3376",
      "NCT04491994",
      "ClinicalTrials.gov",
      "2020-07-28",
      "2020-04-10",
      "True",
      "UNICEF",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Pakistan",
      "Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression",
      "COVID-19",
      "Other",
      "Hydroxychloroquine",
      "Hydroxychloroquine",
      "540",
      "2020-05-31",
      "2020-05-31",
      "https://clinicaltrials.gov/show/NCT04491994",
      "Pre-Print Article",
      "2020-04-08",
      "https://doi.org/10.1101/2020.07.30.20165365",
      "2020-08-31",
      "None"
    ],
    [
      "3556",
      "JPRN-jRCTs041190120",
      "JPRN",
      "2020-03-02",
      "2020-03-02",
      "False",
      "Doi Yohei",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Japan",
      "Favipiravir for SARS-CoV-infected patients",
      "",
      "Drug",
      "Favipiravir",
      "Favipiravir",
      "86",
      "Not Available",
      "2020-06-15",
      "https://jrct.niph.go.jp/latest-detail/jRCTs041190120",
      "Registry Results",
      "2020-08-31",
      "https://jrct.niph.go.jp/en-latest-detail/jRCTs041190120",
      "2020-09-07",
      "None"
    ],
    [
      "3603",
      "NCT04338360",
      "ClinicalTrials.gov",
      "2020-04-03",
      "2020-09-15",
      "False",
      "Mayo Clinic",
      "Not Recruiting",
      "Not Applicable",
      "Expanded Access",
      "United States",
      "Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "Not Available",
      "Not Available",
      "Not Available",
      "https://clinicaltrials.gov/show/NCT04338360",
      "Pre-Print Article",
      "2020-05-14",
      "https://doi.org/10.1101/2020.05.12.20099879",
      "2020-09-14",
      "None"
    ],
    [
      "3604",
      "NCT04338360",
      "ClinicalTrials.gov",
      "2020-04-03",
      "2020-09-15",
      "False",
      "Mayo Clinic",
      "Not Recruiting",
      "Not Applicable",
      "Expanded Access",
      "United States",
      "Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "Not Available",
      "Not Available",
      "Not Available",
      "https://clinicaltrials.gov/show/NCT04338360",
      "Pre-Print Article",
      "2020-08-12",
      "https://doi.org/10.1101/2020.08.12.20169359",
      "2020-09-14",
      "None"
    ],
    [
      "3629",
      "NCT04384055",
      "ClinicalTrials.gov",
      "2020-05-08",
      "2020-03-21",
      "True",
      "Stanford University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "United States",
      "Predicting Outcomes for Covid-19 Using Sonography",
      "POCUS",
      "Prognosis",
      "No Intervention",
      "No Intervention",
      "200",
      "2020-12-31",
      "2020-12-31",
      "https://clinicaltrials.gov/show/NCT04384055",
      "Pre-Print Article",
      "2020-06-28",
      "https://doi.org/10.1101/2020.06.25.20140392",
      "2020-09-14",
      "None"
    ],
    [
      "3746",
      "NCT04275414",
      "ClinicalTrials.gov",
      "2020-02-14",
      "2020-02-15",
      "False",
      "Qilu Hospital of Shandong University",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "China, Italy",
      "Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia",
      "BEST-CP",
      "Drug",
      "Bevacizumab",
      "Bevacizumab",
      "27",
      "2020-04-05",
      "2020-05-02",
      "https://clinicaltrials.gov/show/NCT04275414",
      "Pre-Print Article",
      "2020-07-29",
      "https://doi.org/10.1101/2020.07.26.20159756",
      "2020-09-21",
      "None"
    ],
    [
      "3749",
      "NCT04325646",
      "ClinicalTrials.gov",
      "2020-03-26",
      "2020-03-13",
      "True",
      "Institut Pasteur",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France",
      "CORSER",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "2000",
      "2021-02-28",
      "2023-02-28",
      "https://clinicaltrials.gov/show/NCT04325646",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.04.18.20071134\n\nhttps://doi.org/10.1101/2020.06.25.20140178",
      "2020-09-21",
      "None"
    ],
    [
      "3798",
      "NCT04479293",
      "ClinicalTrials.gov",
      "2020-07-19",
      "2020-07-01",
      "True",
      "Assiut University",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Egypt",
      "Post COVID-19 Functional Status in Egypt",
      "",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "400",
      "2020-10-30",
      "2020-11-30",
      "https://clinicaltrials.gov/show/NCT04479293",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.26.20182618",
      "2020-09-21",
      "None"
    ],
    [
      "3914",
      "NCT04468087",
      "ClinicalTrials.gov",
      "2020-07-03",
      "2020-10-07",
      "False",
      "Hospital do Cora\u00e7\u00e3o",
      "Not Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Brazil",
      "Antiviral Agents Against COVID-19 Infection",
      "REVOLUTIOn",
      "Drug",
      "Atazanavir vs. Daclatasvir vs. Sofusbuvir vs. Favipiravir",
      "Atazanavir; Daclatasvir; Sofusbuvir; Favipiravir",
      "1134",
      "2021-02-28",
      "2021-04-30",
      "https://clinicaltrials.gov/show/NCT04468087",
      "Pre-Print Article",
      "2020-08-31",
      "https://doi.org/10.1101/2020.08.25.20182055",
      "2020-09-28",
      "None"
    ],
    [
      "4008",
      "NCT04320615",
      "ClinicalTrials.gov",
      "2020-03-23",
      "2020-04-03",
      "True",
      "Roche",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "United States, Canada, Germany, Spain, Netherlands, United Kingdom, Italy, France, Denmark",
      "A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia",
      "COVACTA",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "450",
      "2020-06-24",
      "2020-07-28",
      "https://clinicaltrials.gov/show/NCT04320615",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.27.20183442",
      "2020-10-05",
      "EUCTR2020-001154-22"
    ],
    [
      "4015",
      "NCT04343261",
      "ClinicalTrials.gov",
      "2020-04-08",
      "2020-04-10",
      "False",
      "Saint Francis Care",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "United States",
      "Convalescent Plasma in the Treatment of COVID 19",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "48",
      "2020-07-23",
      "2020-08-13",
      "https://clinicaltrials.gov/show/NCT04343261",
      "Pre-Print Article",
      "2020-09-01",
      "https://doi.org/10.1101/2020.08.27.20183293",
      "2020-10-05",
      "None"
    ],
    [
      "4070",
      "NCT04485169",
      "ClinicalTrials.gov",
      "2020-07-21",
      "2020-04-01",
      "True",
      "UNICEF",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "Pakistan",
      "Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;",
      "Plex",
      "ATMP",
      "Plasma",
      "Plasma",
      "280",
      "2020-07-31",
      "2020-07-31",
      "https://clinicaltrials.gov/show/NCT04485169",
      "Pre-Print Article",
      "2020-07-29",
      "https://doi.org/10.1101/2020.07.23.20160796",
      "2020-10-05",
      "None"
    ],
    [
      "4338",
      "NCT04264533",
      "ClinicalTrials.gov",
      "2020-02-04",
      "2020-02-14",
      "False",
      "ZhiYong Peng",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "China",
      "Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia",
      "",
      "Drug",
      "Vitamin C",
      "Vitamin C",
      "56",
      "2020-03-02",
      "2020-03-29",
      "https://clinicaltrials.gov/show/NCT04264533",
      "Pre-Print Article",
      "2020-08-10",
      "https://doi.org/10.21203/rs.3.rs-52778/v1",
      "2020-10-19",
      "None"
    ],
    [
      "4364",
      "NCT04368988",
      "ClinicalTrials.gov",
      "2020-04-24",
      "2020-05-25",
      "False",
      "Novavax",
      "Not Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "United States, Australia",
      "Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant",
      "",
      "ATMP",
      "Vaccine",
      "Vaccine",
      "1419",
      "2020-12-01",
      "2021-11-18",
      "https://clinicaltrials.gov/show/NCT04368988",
      "Pre-Print Article",
      "2020-08-06",
      "https://doi.org/10.1101/2020.08.05.20168435",
      "2020-10-19",
      "None"
    ],
    [
      "4419",
      "NCT04523831",
      "ClinicalTrials.gov",
      "2020-08-19",
      "2020-06-01",
      "True",
      "Dhaka Medical College",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Bangladesh",
      "Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection",
      "",
      "Drug",
      "Ivermectin + Doxycycline",
      "Ivermectin; Doxycycline",
      "400",
      "2020-08-22",
      "2020-09-10",
      "https://clinicaltrials.gov/show/NCT04523831",
      "Registry Results",
      "2020-10-09",
      "https://clinicaltrials.gov/ct2/show/results/NCT04523831",
      "2020-10-19",
      "None"
    ],
    [
      "4509",
      "NCT04345614",
      "ClinicalTrials.gov",
      "2020-04-07",
      "2020-04-08",
      "False",
      "CalciMedica, Inc.",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "United States, Puerto Rico",
      "A Study of Auxora in Patients With Severe COVID-19 Pneumonia",
      "",
      "Drug",
      "CM4620-Injectable Emulsion",
      "CM4620-Injectable Emulsion",
      "400",
      "2020-03-21",
      "2020-04-21",
      "https://clinicaltrials.gov/show/NCT04345614",
      "Journal Article",
      "2020-08-14",
      "https://dx.doi.org/10.1186%2Fs13054-020-03220-x",
      "2020-10-26",
      "None"
    ],
    [
      "4535",
      "NCT04425850",
      "ClinicalTrials.gov",
      "2020-06-08",
      "2020-06-01",
      "True",
      "Eurnekian Public Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Argentina",
      "USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19",
      "IVERCAR",
      "Drug",
      "Ivermectin + Carrageenan",
      "Ivermectin; Carrageenan",
      "229",
      "2020-08-10",
      "2020-08-10",
      "https://clinicaltrials.gov/show/NCT04425850",
      "Registry Results",
      "2020-10-19",
      "https://clinicaltrials.gov/ct2/show/results/NCT04425850",
      "2020-10-26",
      "None"
    ],
    [
      "4664",
      "NCT04317092",
      "ClinicalTrials.gov",
      "2020-03-19",
      "2020-03-19",
      "True",
      "National Cancer Institute",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "Italy",
      "Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)",
      "TOCIVID-19",
      "Drug",
      "Tocilizumab",
      "Tocilizumab",
      "400",
      "2020-12-19",
      "2022-12-19",
      "https://clinicaltrials.gov/show/NCT04317092",
      "Pre-Print Article",
      "2020-06-05",
      "https://doi.org/10.1101/2020.06.01.20119149",
      "2020-11-02",
      "EUCTR2020-001110-38"
    ],
    [
      "4871",
      "DRKS00021578",
      "German Clinical Trials Register",
      "2020-04-28",
      "2020-04-24",
      "True",
      "Universit\u00e4t Konstanz Lehrstuhl",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Germany",
      "Validation of new detection methods for SARS CoV-2 in suspected COVID-19",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "300",
      "Not Available",
      "2020-09-01",
      "http://www.drks.de/DRKS00021578",
      "Pre-Print Article",
      "2020-05-22",
      "https://doi.org/10.1101/2020.05.19.20103150",
      "2020-11-02",
      "None"
    ],
    [
      "4910",
      "DRKS00021152",
      "German Clinical Trials Register",
      "2020-04-07",
      "2020-04-05",
      "True",
      "Hannover Medical School",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Germany",
      "COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "1000",
      "Not Available",
      "Not Available",
      "http://www.drks.de/DRKS00021152",
      "Pre-Print Article",
      "2020-05-18",
      "https://doi.org/10.1101/2020.05.12.20094524",
      "2020-11-02",
      "None"
    ],
    [
      "4916",
      "DRKS00021306",
      "German Clinical Trials Register",
      "2020-04-14",
      "2020-03-31",
      "True",
      "University Hospital, Bonn",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "Germany",
      "Covid-19 Case-Cluster-Study",
      "",
      "Clinical Presentation (Epidemiology)",
      "No Intervention",
      "No Intervention",
      "1400",
      "Not Available",
      "2020-04-09",
      "http://www.drks.de/DRKS00021306",
      "Pre-Print Article",
      "2020-06-02",
      "https://doi.org/10.1101/2020.05.04.20090076",
      "2020-11-02",
      "None"
    ],
    [
      "5049",
      "CTRI/2020/04/024775",
      "CTRI",
      "2020-04-21",
      "2020-04-22",
      "False",
      "Indian Council Of Medical Research",
      "Not Recruiting",
      "Phase 2",
      "Interventional",
      "India",
      "Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.",
      "",
      "ATMP",
      "Plasma",
      "Plasma",
      "452",
      "Not Available",
      "Not Available",
      "http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149",
      "Pre-Print Article",
      "2020-09-08",
      "https://doi.org/10.1101/2020.09.03.20187252",
      "2020-11-04",
      "None"
    ],
    [
      "5825",
      "RPCEC00000307",
      "RPCEC",
      "2020-04-14",
      "2020-04-10",
      "True",
      "Center for Genetic Engineering and Biotechnology (CIGB), Havana",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "Cuba",
      "ESPERANZA study",
      "",
      "Drug",
      "Interferon alpha",
      "Interferon alpha",
      "120",
      "Not Available",
      "2020-07-30",
      "https://rpcec.sld.cu/en/trials/RPCEC00000307-En",
      "Pre-Print Article",
      "2020-08-01",
      "https://doi.org/10.1101/2020.07.29.20164251",
      "2020-11-03",
      "None"
    ],
    [
      "5831",
      "RPCEC00000313",
      "RPCEC",
      "2020-05-14",
      "2020-03-31",
      "True",
      "Center for Genetic Engineering and Biotechnology (CIGB), Havana",
      "Not Recruiting",
      "Not Applicable",
      "Interventional",
      "Cuba",
      "CIGB-258 at COVID-19",
      "",
      "Drug",
      "CIGB-258",
      "CIGB-258",
      "16",
      "Not Available",
      "2020-04-30",
      "https://rpcec.sld.cu/en/trials/RPCEC00000313-En",
      "Pre-Print Article",
      "2020-06-02",
      "https://doi.org/10.1101/2020.05.27.20110601",
      "2020-11-03",
      "None"
    ],
    [
      "5836",
      "RPCEC00000318",
      "RPCEC",
      "2020-05-29",
      "2020-03-11",
      "True",
      "National Board of Science and Technology of the Ministry of Public Health (MINSAP)",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "Cuba",
      "Heberon Alfa R in COVID-19",
      "",
      "Drug",
      "Interferon alpha",
      "Interferon alpha",
      "0",
      "Not Available",
      "2020-08-14",
      "https://rpcec.sld.cu/en/trials/RPCEC00000318-En",
      "Pre-Print Article",
      "2020-09-06",
      "https://doi.org/10.1101/2020.05.29.20109199",
      "2020-11-03",
      "None"
    ],
    [
      "5880",
      "NCT04280705",
      "ClinicalTrials.gov",
      "2020-02-20",
      "2020-02-21",
      "True",
      "National Institute of Allergy and Infectious Diseases (NIAID)",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "United States, Mexico, Germany, Spain, Greece, United Kingdom, Singapore, Japan, South Korea, Denmark",
      "Adaptive COVID-19 Treatment Trial (ACTT)",
      "",
      "Drug",
      "Remdesivir",
      "Remdesivir",
      "1062",
      "2020-05-21",
      "2020-05-21",
      "https://clinicaltrials.gov/show/NCT04280705",
      "Journal Article",
      "2020-05-22",
      "https://doi.org/10.1056/nejmoa2007764",
      "2020-11-09",
      "EUCTR2020-001052-18; JPRN-jRCT2031190264"
    ],
    [
      "5881",
      "NCT04290780",
      "ClinicalTrials.gov",
      "2020-02-27",
      "2020-03-09",
      "False",
      "Hospices Civils de Lyon",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus",
      "NOSO-COR",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "300",
      "2020-12-31",
      "2020-12-31",
      "https://clinicaltrials.gov/show/NCT04290780",
      "Pre-Print Article",
      "2020-06-12",
      "https://doi.org/10.1101/2020.06.09.20125286",
      "2020-11-09",
      "None"
    ],
    [
      "5885",
      "NCT04324736",
      "ClinicalTrials.gov",
      "2020-03-25",
      "2020-03-10",
      "True",
      "Nantes University Hospital",
      "Not Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "\"COVID-19 and Diabetes Outcomes\"",
      "CORONADO",
      "Clinical Presentation",
      "No Intervention",
      "No Intervention",
      "5309",
      "2020-04-10",
      "2020-12-31",
      "https://clinicaltrials.gov/show/NCT04324736",
      "Journal Article",
      "2020-05-29",
      "https://doi.org/10.1007/s00125-020-05180-x",
      "2020-11-09",
      "None"
    ],
    [
      "5891",
      "NCT04333420",
      "ClinicalTrials.gov",
      "2020-04-01",
      "2020-03-31",
      "True",
      "InflaRx GmbH",
      "Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "Germany, Netherlands",
      "Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",
      "PANAMO",
      "Drug",
      "IFX-1",
      "IFX-1",
      "390",
      "2021-05-31",
      "2021-08-31",
      "https://clinicaltrials.gov/show/NCT04333420",
      "Pre-Print Article",
      "2020-07-30",
      "https://dx.doi.org/10.2139/ssrn.3658226",
      "2020-11-09",
      "EUCTR2020-001335-28"
    ],
    [
      "5900",
      "NCT04343092",
      "ClinicalTrials.gov",
      "2020-04-05",
      "2020-04-18",
      "False",
      "University of Baghdad",
      "Not Recruiting",
      "Phase 1",
      "Interventional",
      "Iraq",
      "Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management",
      "",
      "Drug",
      "Ivermectin + hydroxychloroquine vs. hydroxychloroquine",
      "Ivermectin; hydroxychloroquine",
      "16",
      "2020-05-31",
      "2020-06-01",
      "https://clinicaltrials.gov/show/NCT04343092",
      "Pre-Print Article",
      "2020-07-08",
      "https://doi.org/10.1101/2020.07.07.20145979",
      "2020-11-09",
      "None"
    ],
    [
      "5928",
      "NCT04368728",
      "ClinicalTrials.gov",
      "2020-04-27",
      "2020-04-29",
      "False",
      "Biontech SE",
      "Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "United States, Germany, Argentina, South Africa, Brazil, Turkey",
      "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",
      "",
      "ATMP",
      "Vaccine",
      "Vaccine",
      "43998",
      "2021-06-13",
      "2022-12-11",
      "https://clinicaltrials.gov/show/NCT04368728",
      "Pre-Print Article",
      "2020-07-01",
      "https://doi.org/10.1101/2020.06.30.20142570",
      "2020-11-09",
      "None"
    ],
    [
      "5976",
      "NCT04411667",
      "ClinicalTrials.gov",
      "2020-05-29",
      "2020-04-28",
      "True",
      "Dr. George Sakoulas",
      "Not Recruiting",
      "Phase 4",
      "Interventional",
      "United States",
      "Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19",
      "",
      "ATMP",
      "Immunoglobulin",
      "Immunoglobulin",
      "34",
      "2020-11-01",
      "2020-11-30",
      "https://clinicaltrials.gov/show/NCT04411667",
      "Pre-Print Article",
      "2020-07-25",
      "https://doi.org/10.1101/2020.07.20.20157891",
      "2020-11-09",
      "None"
    ],
    [
      "6023",
      "NCT04491240",
      "ClinicalTrials.gov",
      "2020-07-27",
      "2020-07-20",
      "True",
      "Samara Regional Medical Center Dinasty",
      "Not Recruiting",
      "Phase 1/Phase 2",
      "Interventional",
      "Russian Federation",
      "Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.",
      "COVID-19EXO",
      "Procedure",
      "Exosome Inhalation",
      "Exosome Inhalation",
      "30",
      "2020-10-01",
      "2020-10-20",
      "https://clinicaltrials.gov/show/NCT04491240",
      "Registry Results",
      "2020-11-04",
      "https://clinicaltrials.gov/ct2/show/results/NCT04491240",
      "2020-11-09",
      "None"
    ],
    [
      "6062",
      "NCT04542694",
      "ClinicalTrials.gov",
      "2020-09-04",
      "2020-05-21",
      "True",
      "Promomed, LLC",
      "Not Recruiting",
      "Phase 3",
      "Interventional",
      "Russian Federation",
      "Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19",
      "",
      "Drug",
      "Favipiravir",
      "Favipiravir",
      "200",
      "2020-08-10",
      "2020-08-20",
      "https://clinicaltrials.gov/show/NCT04542694",
      "Registry Results",
      "2020-11-05",
      "https://clinicaltrials.gov/ct2/show/results/NCT04542694",
      "2020-11-09",
      "None"
    ],
    [
      "6399",
      "NCT04323527",
      "ClinicalTrials.gov",
      "2020-03-13",
      "2020-03-23",
      "False",
      "Funda\u00e7\u00e3o de Medicina Tropical Dr. Heitor Vieira Dourado",
      "Recruiting",
      "Phase 2",
      "Interventional",
      "Brazil",
      "Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)",
      "",
      "Drug",
      "Chloroquine",
      "Chloroquine",
      "440",
      "2020-05-07",
      "2020-06-07",
      "https://clinicaltrials.gov/ct2/show/NCT04323527",
      "Journal Article",
      "2020-04-24",
      "https://doi.org/10.1001/jamanetworkopen.2020.8857",
      "2020-04-14",
      "None"
    ],
    [
      "6403",
      "NCT04337424",
      "ClinicalTrials.gov",
      "2020-04-05",
      "2020-04-13",
      "False",
      "University Hospital, Montpellier",
      "Recruiting",
      "Not Applicable",
      "Observational",
      "France",
      "Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 (EasyCoV)",
      "",
      "Diagnostics",
      "Diagnostic Test or Assessment",
      "Diagnostic Test or Assessment",
      "180",
      "2020-10-07",
      "2020-10-07",
      "https://clinicaltrials.gov/ct2/show/NCT04337424",
      "Pre-Print Article",
      "2020-05-30",
      "https://doi.org/10.1101/2020.05.30.20117291",
      "2020-04-30",
      "None"
    ],
    [
      "6404",
      "NCT04381936",
      "ClinicalTrials.gov",
      "2020-05-07",
      "2020-03-19",
      "True",
      "University of Oxford",
      "Recruiting",
      "Phase 2/Phase 3",
      "Interventional",
      "United Kingdom",
      "Randomized Evaluation of COVID-19 Therapy",
      "",
      "Drug (+ ATMP)",
      "Lopinavir/ritonavir, Corticosteroids, hydroxychloroquine, azithromycin, tocilizumab, Plasma, REGN10933+REGN10987, Aspirin",
      "Lopinavir/ritonavir; dexamethasone; hydrocortisone; methylprednisolone; hydroxychloroquine; azithromycin; tocilizumab; Plasma; REGN10933; REGN10987; Aspirin",
      "12000",
      "2020-12-21",
      "2020-12-31",
      "https://clinicaltrials.gov/ct2/show/NCT04381936",
      "Pre-Print Article",
      "No Results",
      "https://doi.org/10.1101/2020.06.22.20137273\n\nhttps://doi.org/10.1101/2020.07.15.20151852",
      "2020-06-05",
      "EUCTR2020-001113-21; ISRCTN50189673"
    ]
  ]
}